California Public Employees Retirement System’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-35,900
Closed -$2K 3481
2016
Q4
$2K Hold
35,900
﹤0.01% 3433
2016
Q3
$6K Hold
35,900
﹤0.01% 3475
2016
Q2
$11K Hold
35,900
﹤0.01% 3536
2016
Q1
$6K Hold
35,900
﹤0.01% 3578
2015
Q4
$62K Hold
35,900
﹤0.01% 3463
2015
Q3
$67K Hold
35,900
﹤0.01% 3473
2015
Q2
$84K Hold
35,900
﹤0.01% 3503
2015
Q1
$205K Hold
35,900
﹤0.01% 3411
2014
Q4
$205K Hold
35,900
﹤0.01% 3411
2014
Q3
$149K Hold
35,900
﹤0.01% 3489
2014
Q2
$211K Buy
35,900
+5,618
+19% +$31.9K ﹤0.01% 3411
2014
Q1
$205K Sell
30,282
-9,975
-25% -$90K ﹤0.01% 3386
2013
Q4
$331K Buy
+40,257
New +$314K ﹤0.01% 3138

California Public Employees Retirement System's TLOG Position: Q1 2017 in Review

California Public Employees Retirement System sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2017, closing a stake of 35,900 shares — an estimated $2K sold.

California Public Employees Retirement System first reported a position in TLOG in Q4 2013 and held it in 13 quarters. The position peaked at $331K in Q4 2013. 2 funds tracked by Wall St. Rank hold TLOG as of Q1 2017.

  • California Public Employees Retirement System reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2017 after selling out during the quarter.
  • California Public Employees Retirement System sold 35,900 TetraLogic Pharmaceuticals Corporation shares in Q1 2017, an estimated $2K.
  • California Public Employees Retirement System first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2013 and held it in 13 quarters.
  • California Public Employees Retirement System's TetraLogic Pharmaceuticals Corporation position peaked at $331K in Q4 2013.
  • 2 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2017.

Based on California Public Employees Retirement System's 13F filing for Q1 2017, filed 11 May 2017.